Matthias E. Goebeler

Josef Schneider Str. 2
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 299 publications

Rapid regression of a mucosal melanoma after a single dose of immune checkpoint inhibitors.

Rapid regression of a mucosal melanoma after a single dose of immune checkpoint inhibitors.

Journal: European journal of dermatology : EJD

Published: May 25, 2026

Early Detection of Melanoma

Early Detection of Melanoma

Journal: MMW Fortschritte der Medizin

Published: May 12, 2026

Eosinophilia Reflects Type 2 Immune Activation in Newly Diagnosed Bullous Pemphigoid, With No Evidence of Charcot-Leyden Crystals.

Eosinophilia Reflects Type 2 Immune Activation in Newly Diagnosed Bullous Pemphigoid, With No Evidence of Charcot-Leyden Crystals.

Journal: Allergy

Published: March 05, 2026

AXL is a novel ERK5/KLF4 target in MEK inhibitor-treated melanoma.

AXL is a novel ERK5/KLF4 target in MEK inhibitor-treated melanoma.

Journal: Neoplasia (New York, N.Y.)

Published: February 17, 2026

Immune checkpoint inhibitor-induced bullous pemphigoid effectively controlled by dupilumab.

Immune checkpoint inhibitor-induced bullous pemphigoid effectively controlled by dupilumab.

Journal: European journal of dermatology : EJD

Published: January 29, 2026

Patient Preferences in Hidradenitis Suppurativa Depend on Treatment Experience: Results from APProach-HS.

Patient Preferences in Hidradenitis Suppurativa Depend on Treatment Experience: Results from APProach-HS.

Journal: Patient preference and adherence

Published: January 03, 2026

Joint Assessment Matters: Diagnostic and Therapeutic Benefits of Interdisciplinary Psoriasis Care.

Joint Assessment Matters: Diagnostic and Therapeutic Benefits of Interdisciplinary Psoriasis Care.

Journal: Advances in therapy

Published: December 11, 2025

Author Correction: TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2.

Author Correction: TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2.

Journal: Nature

Published: November 06, 2025

Mogamulizumab-associated rash and lymphocytopenia coinciding with treatment response of Sézary syndrome.

Mogamulizumab-associated rash and lymphocytopenia coinciding with treatment response of Sézary syndrome.

Journal: European journal of dermatology : EJD

Published: September 18, 2025

Clinical pearl: Topical Lactobacillus application to disrupt Pseudomonas aeruginosa biofilms and promote healing in chronic wounds.

Clinical pearl: Topical Lactobacillus application to disrupt Pseudomonas aeruginosa biofilms and promote healing in chronic wounds.

Journal: Journal of the American Academy of Dermatology

Published: September 15, 2025

Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective Study.

Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective Study.

Journal: Acta dermato-venereologica

Published: September 07, 2025

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 21, 2025

Showing 1-12 of 299

Last Updated: 09/26/2026